This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Epizyme
EPZM
$1.47
Share price
0.00%
Change (1 day)
-65.57%
Change (1 year)
Categories
Earnings for Epizyme (EPZM)
Earnings in 2022 (TTM): -$0.22 Billion USD
According to Epizyme's latest financial reports the company's current earnings are $53 Million USD. In 2021 the company made an earning of -$0.23 Billion USD a decrease over its 2020 earnings that were of -$0.23 Billion USD.
Earnings history for Epizyme from 2012 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$0.22 Billion | -6.53% |
| 2021 | -$0.23 Billion | 0.63% |
| 2020 | -$0.23 Billion | 32.62% |
| 2019 | -$0.18 Billion | 32.74% |
| 2018 | -$0.13 Billion | -6.38% |
| 2017 | -$0.14 Billion | 22.37% |
| 2016 | -$0.12 Billion | -15.63% |
| 2015 | -$0.14 Billion | 140.78% |
| 2014 | -$55.05 Million | 1660.47% |
| 2013 | -$3.13 Million | 307.16% |
| 2012 | -$0.77 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -$0.8 Billion | 330.61% | 🇺🇸 USA |
 | $13.64 B | -7,529.44% | 🇨🇭 Switzerland |
 | $4.39 B | -2,493.62% | 🇬🇧 UK |
 | $7.01 B | -3,919.84% | 🇺🇸 USA |